Winning Health(SZ:300253)2026-02-12 07:46Financial Performance - The company expects a net loss attributable to shareholders for 2025 between RMB 390 million and RMB 320 million, compared to a profit of RMB 87.89 million in the same period last year [2]. - The projected net loss after deducting non-recurring gains and losses is expected to be between RMB 374 million and RMB 304 million, down from a profit of RMB 124.18 million in the previous year [2]. - The decline in performance is attributed to multiple factors including macroeconomic conditions, fluctuations in industry demand, and intensified market competition [3]. - The company's overall revenue has decreased due to the WiNEX product not yet generating significant income during its upgrade and replacement phase [3]. - The company has faced additional pressures from asset impairment provisions, goodwill impairment, and tax payments, contributing to profit declines [4]. Cash Flow and Liquidity - As of September 2025, the company had cash reserves of RMB 1.224 billion, indicating relatively sufficient liquidity [4]. - Cash flows from operating and investing activities showed a net outflow during the first nine months of 2025, raising concerns about cash flow stability under current operating conditions [4]. Credit Rating and Financial Management - The company's credit rating remains at AA with a stable outlook, reflecting ongoing monitoring of the healthcare information technology sector and the company's governance and financial status [4]. - The rating agency will continue to track developments in the healthcare information technology industry and their potential impact on the company's credit rating and outlook [4]. - The company’s leverage status is rated 9/9, indicating strong financial leverage management despite the current challenges [6].